Conditions Requiring Higher Doses of Cisatracurium

Physiological Conditions Requiring Higher Doses

Up-regulation of nicotinic acetylcholine receptors occurs in conditions with chronic damage to motoneurons, extensive deep burns, or prolonged critical illness, requiring higher doses of non-depolarizing muscle relaxants due to reduced sensitivity 1

Patients with moderate to severe ARDS who cannot achieve lung-protective ventilation with deep sedation alone may require continuous cisatracurium infusion, typically starting with a 15 mg bolus followed by 37.5 mg/h for up to 48 hours 2, 3, 4
Patients with dyssynchronous ventilation, who are persistently hypoxemic, ventilated in prone position, or at risk for injurious ventilation, may require higher doses of cisatracurium to achieve adequate neuromuscular blockade 3, 5

Patients with myasthenia or primary muscle damage (myopathies) show increased sensitivity to non-depolarizing muscle relaxants and require 50-75% reduction in cisatracurium dosing 1
The American Society of Anesthesiologists recommends benzylisoquinoline muscle relaxants like cisatracurium in patients with renal or hepatic failure, but dosing should be carefully monitored 1
Obese patients should receive cisatracurium based on ideal body weight rather than actual body weight 6

Train-of-four (TOF) monitoring is essential for individualizing cisatracurium dosing in all patients, especially those with conditions that might alter drug response 1, 2, 3
Continuous assessment of neuromuscular function is crucial to avoid overdosing while maintaining adequate blockade in patients receiving cisatracurium infusions 3, 5